Search companies or stocks...
MYGNMyriad Genetics, Inc.
At close · 02 Sept 2026, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company…
Current stock price of Myriad Genetics, Inc. (MYGN) stock is $3.230. The stock price is +1.57% higher in the session. The intraday range can be seen from this page. Volume of Myriad Genetics, Inc. (MYGN) stock is 1.35M.
Last updated at 02 Sept 2026, 08:00 pm.
The stock price of Myriad Genetics, Inc. (MYGN) can change with earnings, company news, and overall market sentiment. Myriad Genetics, Inc. operates in the Healthcare / Medical - Diagnostics & Research market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Myriad Genetics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for MYGN on this page is -24.85. EPS on this page is -0.13. Compare those figures with peers and growth expectations before deciding if the current Myriad Genetics, Inc. price is justified.
Historical performance for Myriad Genetics, Inc. (MYGN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how MYGN reacted to past earnings and market events.
Buying Myriad Genetics, Inc. (MYGN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
